Status: current, Defined. Date: 30-Sep 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4457931000168111 | dinutuximab beta 20 mg / 4.5 mL injection, 4.5 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4457941000168119 | dinutuximab beta 20 mg/4.5 mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| dinutuximab beta 20 mg/4.5 mL injection, vial | Is a | dinutuximab beta | true | Inferred relationship | Some | ||
| dinutuximab beta 20 mg/4.5 mL injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| dinutuximab beta 20 mg/4.5 mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| dinutuximab beta 20 mg/4.5 mL injection, vial | has intended active ingredient | dinutuximab beta | true | Inferred relationship | Some | 1851944681 | |
| dinutuximab beta 20 mg/4.5 mL injection, vial | has Australian BoSS | dinutuximab beta | true | Inferred relationship | Some | 1851944681 | |
| dinutuximab beta 20 mg/4.5 mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 629573697 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Qarziba 20 mg/4.5 mL injection, 4.5 mL vial | Is a | True | dinutuximab beta 20 mg/4.5 mL injection, vial | Inferred relationship | Some | |
| dinutuximab beta 20 mg/4.5 mL injection, 4.5 mL vial | has MPUU | True | dinutuximab beta 20 mg/4.5 mL injection, vial | Inferred relationship | Some | 1760074065 |
Reference Sets
Medicinal product unit of use reference set
FHIR